These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11751726)

  • 1. Cardiomyocyte apoptotic cell death in arterial hypertension: mechanisms and potential management.
    Fortuño MA; Ravassa S; Fortuño A; Zalba G; Díez J
    Hypertension; 2001 Dec; 38(6):1406-12. PubMed ID: 11751726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiomyocyte apoptosis in hypertensive cardiomyopathy.
    González A; Fortuño MA; Querejeta R; Ravassa S; López B; López N; Díez J
    Cardiovasc Res; 2003 Sep; 59(3):549-62. PubMed ID: 14499856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of cardiomyocyte survival-apoptosis balance in hypertensive cardiac remodeling.
    Fortuño MA; López N; González A; Díez J
    Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):293-307. PubMed ID: 15030288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Apoptosis in hypertensive cardiopathy].
    Díez J; Fortuño MA; Ravassa S
    Rev Esp Cardiol; 1999; 52 Suppl 3():18-24. PubMed ID: 10614145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel mechanism of angiotensin II-induced cardiac injury in hypertensive rats: the critical role of ASK1 and VEGF.
    Nako H; Kataoka K; Koibuchi N; Dong YF; Toyama K; Yamamoto E; Yasuda O; Ichijo H; Ogawa H; Kim-Mitsuyama S
    Hypertens Res; 2012 Feb; 35(2):194-200. PubMed ID: 22089532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Xin-Ji-Er-Kang formula on 2K1C-induced hypertension and cardiovascular remodeling in rats.
    Guo K; Lan CZ; Yu TT; Huang LL; Wang XH; Pan C; Gao S
    J Ethnopharmacol; 2014 Sep; 155(2):1227-35. PubMed ID: 25063306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemin decreases cardiac oxidative stress and fibrosis in a rat model of systemic hypertension via PI3K/Akt signalling.
    Worou ME; Belmokhtar K; Bonnet P; Vourc'h P; Machet MC; Khamis G; Eder V
    Cardiovasc Res; 2011 Jul; 91(2):320-9. PubMed ID: 21406596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A state of reversible compensated ventricular dysfunction precedes pathological remodelling in response to cardiomyocyte-specific activity of angiotensin II type-1 receptor in mice.
    Frentzou GA; Drinkhill MJ; Turner NA; Ball SG; Ainscough JF
    Dis Model Mech; 2015 Aug; 8(8):783-94. PubMed ID: 26092119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II-mediated phenotypic cardiomyocyte remodeling leads to age-dependent cardiac dysfunction and failure.
    Domenighetti AA; Wang Q; Egger M; Richards SM; Pedrazzini T; Delbridge LM
    Hypertension; 2005 Aug; 46(2):426-32. PubMed ID: 15998712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro.
    Kojima M; Shiojima I; Yamazaki T; Komuro I; Zou Z; Wang Y; Mizuno T; Ueki K; Tobe K; Kadowaki T
    Circulation; 1994 May; 89(5):2204-11. PubMed ID: 8181146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the renin-angiotensin system in cardiac hypertrophy.
    Yamazaki T; Komuro I; Yazaki Y
    Am J Cardiol; 1999 Jun; 83(12A):53H-57H. PubMed ID: 10750588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of cardiac apoptosis in essential hypertension: potential role of angiotensin II.
    González A; López B; Ravassa S; Querejeta R; Larman M; Díez J; Fortuño MA
    Hypertension; 2002 Jan; 39(1):75-80. PubMed ID: 11799082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis, myocardial fibrosis and angiotensin II in the left ventricle of hypertensive rats treated with fosinopril or losartan.
    Yu G; Liang X; Xie X; Yang T; Sun M; Zhao S
    Chin Med J (Engl); 2002 Sep; 115(9):1287-91. PubMed ID: 12411096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective PDE5A inhibition with sildenafil rescues left ventricular dysfunction, inflammatory immune response and cardiac remodeling in angiotensin II-induced heart failure in vivo.
    Westermann D; Becher PM; Lindner D; Savvatis K; Xia Y; Fröhlich M; Hoffmann S; Schultheiss HP; Tschöpe C
    Basic Res Cardiol; 2012 Nov; 107(6):308. PubMed ID: 23117837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of cardiac function, geometry, energetics and coronary reserve in hypertensive heart disease.
    Strauer BE
    Nephron; 1987; 47 Suppl 1():76-86. PubMed ID: 2962004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of levosimendan on cardiac remodeling and cardiomyocyte apoptosis in hypertensive Dahl/Rapp rats.
    Louhelainen M; Vahtola E; Kaheinen P; Leskinen H; Merasto S; Kytö V; Finckenberg P; Colucci WS; Levijoki J; Pollesello P; Haikala H; Mervaala EM
    Br J Pharmacol; 2007 Apr; 150(7):851-61. PubMed ID: 17325658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of increased susceptibility to angiotensin II-induced apoptosis in ventricular cardiomyocytes of spontaneously hypertensive rats.
    Ravassa S; Fortuño MA; González A; López B; Zalba G; Fortuño A; Díez J
    Hypertension; 2000 Dec; 36(6):1065-71. PubMed ID: 11116126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of non-cardiomyocyte apoptosis to cardiac remodelling that occurs in the transition from compensated hypertrophy to heart failure in spontaneously hypertensive rats.
    Ikeda S; Hamada M; Hiwada K
    Clin Sci (Lond); 1999 Aug; 97(2):239-46. PubMed ID: 10409480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Contrast of losartan, fosinopril and amlodipine on cardiomyocyte apoptosis and left ventricular remolding in hypertensive rats].
    Yu GL; Liang XQ; Zheng JQ
    Hunan Yi Ke Da Xue Xue Bao; 2001 Oct; 26(5):405-8. PubMed ID: 12536482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial remodeling in hypertension.
    Nadruz W
    J Hum Hypertens; 2015 Jan; 29(1):1-6. PubMed ID: 24804791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.